Ispecimen Stock Performance

ISPC Stock  USD 0.30  0.02  5.47%   
The company retains a Market Volatility (i.e., Beta) of 3.36, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ISpecimen will likely underperform. At this point, iSpecimen has a negative expected return of -1.42%. Please make sure to check out ISpecimen's potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if iSpecimen performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days iSpecimen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2026. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Last Split Factor
1:20
Last Split Date
2024-09-16
1
Real time breakdown of iSpecimen Inc. stock performance - Oil Prices Free Technical Confirmation Trade Alerts - newser.com
10/24/2025
2
iSpecimen Delays Q3 2025 10-Q Filing - TipRanks
11/14/2025
3
How iSpecimen Inc. stock reacts to inflationary pressures - Quarterly Trade Summary Risk Managed Investment Entry Signals - newser.com
11/19/2025
4
iSpecimen Regains Nasdaq Compliance as of November 2025 - The Globe and Mail
12/02/2025
5
Aug Volume How iSpecimen Inc. stock performs after earnings - Trade Risk Assessment Free Low Drawdown Momentum Trade Ideas -
12/18/2025
6
iSpecimen Inc. Announces Pricing of 5.5 Million Private Placement
12/30/2025
7
iSpecimen Inc Stock Surged 42 percent After-Hours Heres The News Behind The Move
12/31/2025
8
iSpecimen Postpones Annual Meeting Due to Lack Quorum - TipRanks
01/05/2026
9
Why iSpecimen Inc. stock is considered a top pick - July 2025 Sentiment Fast Entry High Yield Tips - ulpravda.ru
01/08/2026
Begin Period Cash Flow2.3 M
Total Cashflows From Investing ActivitiesM
Free Cash Flow-8.3 M

ISpecimen Relative Risk vs. Return Landscape

If you would invest  83.00  in iSpecimen on October 11, 2025 and sell it today you would lose (52.75) from holding iSpecimen or give up 63.55% of portfolio value over 90 days. iSpecimen is currently does not generate positive expected returns and assumes 6.2504% risk (volatility on return distribution) over the 90 days horizon. In different words, 56% of stocks are less volatile than ISpecimen, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days ISpecimen is expected to under-perform the market. In addition to that, the company is 8.84 times more volatile than its market benchmark. It trades about -0.23 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.16 per unit of volatility.

ISpecimen Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for ISpecimen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as iSpecimen, and traders can use it to determine the average amount a ISpecimen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.2269

High ReturnsBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsISPC
Based on monthly moving average ISpecimen is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ISpecimen by adding ISpecimen to a well-diversified portfolio.

ISpecimen Fundamentals Growth

ISpecimen Stock prices reflect investors' perceptions of the future prospects and financial health of ISpecimen, and ISpecimen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ISpecimen Stock performance.

About ISpecimen Performance

By analyzing ISpecimen's fundamental ratios, stakeholders can gain valuable insights into ISpecimen's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ISpecimen has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ISpecimen has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 8.48  6.69 
Return On Tangible Assets(3.57)(3.40)
Return On Capital Employed(4.09)(3.88)
Return On Assets(1.20)(1.26)
Return On Equity(4.34)(4.12)

Things to note about iSpecimen performance evaluation

Checking the ongoing alerts about ISpecimen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for iSpecimen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
iSpecimen generated a negative expected return over the last 90 days
iSpecimen has high historical volatility and very poor performance
iSpecimen has some characteristics of a very speculative penny stock
iSpecimen has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 9.29 M. Net Loss for the year was (12.5 M) with profit before overhead, payroll, taxes, and interest of 722.54 K.
iSpecimen currently holds about 23.69 M in cash with (8.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.67, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
iSpecimen has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Why iSpecimen Inc. stock is considered a top pick - July 2025 Sentiment Fast Entry High Yield Tips - ulpravda.ru
Evaluating ISpecimen's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate ISpecimen's stock performance include:
  • Analyzing ISpecimen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ISpecimen's stock is overvalued or undervalued compared to its peers.
  • Examining ISpecimen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating ISpecimen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ISpecimen's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of ISpecimen's stock. These opinions can provide insight into ISpecimen's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating ISpecimen's stock performance is not an exact science, and many factors can impact ISpecimen's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for ISpecimen Stock analysis

When running ISpecimen's price analysis, check to measure ISpecimen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ISpecimen is operating at the current time. Most of ISpecimen's value examination focuses on studying past and present price action to predict the probability of ISpecimen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ISpecimen's price. Additionally, you may evaluate how the addition of ISpecimen to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes